QUALITY IMPROVEMENT P982 - ESOC25-2120 ECONOMIC BURDEN OF STROKE ACROSS 37 EUROPEAN COUNTRIES: A POPULATION-BASED COST STUDY Ramon Luengo-Fernandez 1 , Marjan Walli-Attaei 1 , Alastair Gray 1 , Aleksandra Torbica 2 , Aldo Maggioni 3 , Radu Huculeci 4 , Victor Aboyans 5 , Adam Timmis 6 , Panos Vardas 7 , Jose Leal 1 1 University of Oxford, Oxford, United Kingdom, 2 Bocconi University, Milan, Italy, 3 Heart Care Foundation, Florence, Italy, 4 European Society of Cardiology, Nice, France, 5 University Hospital of Limoges, Limoges, France, 6 Queen Mary University of London, London, United Kingdom, 7 Hygeia Hospitals Group, Athens, Greece Background and Aims: Previous pan-European estimates of the economic burden of stroke have been undertaken
In recent years, there has been increasing research on copper and zinc nanoparticles as well as different metals and nanoparticle forms such as metal oxides, all having potential effects on the cardiovascular system (160)
Baele, M
Aarhus L, Homoe P, Engdahl B
L-Cysteine l mt amino acid c vai tr trong qu trnh tng hp glutathione cht chng oxy ha ni sinh
HIV medications Some HIV medications, especially certain protease inhibitors and non-nucleoside reverse transcriptase inhibitors, can affect the levels of birth control hormones in the body, either increasing or decreasing their presence, which could impact their effectiveness
